Annotation of rs7668258
Genotype CT is associated with increased concentrations of valproic acid in people with Epilepsy as compared to genotype CC.
In overall analysis CT genotype was associated with increased serum concentration of valproic acid as compared with the CC genotype (P = 0.01) as well as in the sub-group analysis in combination therapy (P = 0.04). Hoqever, the CT genotype also did not significantly affect the adjusted serum concentration as compared with CC genotype based on monotherapy data (P = 0.10).
From Publication
Gene
Variant
Phenotype Category
Association Significance
Specialty Population
PharmGKB ID
Score More info on scoring
Evidence for Clinical Annotations
This annotation has been used as evidence for the following clinical annotations.
Study Parameters
1.
Study type
Study size
Association p-value
Biogeographical group More info on groups
Population description
Drug: VPA dose adj. concentration; 2 sub-group study in patients on VPA combined therapy
2.
Study type
Study size
Association p-value
Biogeographical group More info on groups
Population description
Drug: VPA dose adj. concentration; overall from 4 studies in patients on VPA monotherapy and combination
3.
Study type
Study size
Association p-value
Biogeographical group More info on groups
Population description
Drug: VPA dose adj. concentration; 2 studies in patients on VPA monotherapy sub-study
Note: Alleles in PharmGKB are mapped to the positive chromosomal strand. Therefore, variants in genes on the "minus" strand (eg. VKORC1) are complemented in PharmGKB annotations.